Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1904-2025Class I

Broselow Pediatric Emergency Rainbow Tape (distribution by AirLife); REF 7700REA AirLife brand, 2025 Edition...

Salter Labs / initiated 2025-05-15 / Open, Classified / root cause: manufacturing process

SunMed Holdings, LLC began a recall of Broselow Pediatric Emergency Rainbow Tape (distribution by AirLife); REF 7700REA AirLife brand, 2025 Edition, and 36-23446 Rev 2 Print Version The Broselow... on . FDA classified it as Class I and gives the reason as "The impacted tape was manufactured with incorrect information on the tape. Incorrect values are printed in the Red zone, Orange zone, and Grey zone. Using the incorrect values in the Red zone could lead to shocking a...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1904-2025
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
Salter Labs
Product
Broselow Pediatric Emergency Rainbow Tape (distribution by AirLife); REF 7700REA AirLife brand, 2025 Edition, and 36-23446 Rev 2 Print Version The Broselow Tape is a length- and weight-based reference tool specifically designed for pediatric emergency care.
Product code
OKI Emergency Response Safety Kit
Reason for recall
The impacted tape was manufactured with incorrect information on the tape. Incorrect values are printed in the Red zone, Orange zone, and Grey zone. Using the incorrect values in the Red zone could lead to shocking a patient with an excessive dose of joules, causing significant harm including burns, heart damage, and cardiac arrest. Incorrect values in the Orange zone could lead to overdosing the patient with sodium bicarbonate and cause metabolic alkalosis, electrolyte imbalances, tissue damage, and worsen respiratory status. Incorrect information in the Grey may lead to underdosing the patient with sodium bicarbonate and may cause reduced myocardial contractility, decreased response to vasopressors, and increased risk of dysrhythmia.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On May 15, 2025, the firm began notifying customers via Urgent Medical Device Recall letters. Customers were given detailed information about the incorrect information printed on the tape. Customers were instructed to identify and quarantine all affected product in inventory. Customers should destroy and dispose of all affected product. If product was further distributed, distributors should identify their customers/consignees and notify them of the recall. The firm will provide replacement products once customer confirms destruction of affected product.
Quantity in commerce
9900 eaches
Distribution
US distribution nationwide. International distribution to Canada.
Product codes and lots
UDI-DI EA: 10889483588970 CS: 30889483588974 Lot 0004316661

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1904-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1904-2025Class IOngoingVoluntary: Firm initiated